Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 4
1971 6
1972 6
1973 7
1974 5
1975 10
1976 7
1977 9
1978 8
1979 5
1980 8
1981 4
1982 4
1983 10
1984 10
1985 14
1986 22
1987 25
1988 17
1989 22
1990 21
1991 20
1992 12
1993 24
1994 19
1995 18
1996 15
1997 16
1998 12
1999 22
2000 17
2001 16
2002 16
2003 14
2004 14
2005 17
2006 11
2007 20
2008 19
2009 10
2010 19
2011 12
2012 12
2013 13
2014 14
2015 10
2016 12
2017 15
2018 15
2019 17
2020 24
2021 22
2022 13
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

724 results

Results by year

Filters applied: . Clear all
Page 1
Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment.
Gulley JL, Schlom J, Barcellos-Hoff MH, Wang XJ, Seoane J, Audhuy F, Lan Y, Dussault I, Moustakas A. Gulley JL, et al. Among authors: schlom j. Mol Oncol. 2022 Jun;16(11):2117-2134. doi: 10.1002/1878-0261.13146. Epub 2022 Jan 4. Mol Oncol. 2022. PMID: 34854206 Free PMC article. Review.
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer.
Redman JM, Friedman J, Robbins Y, Sievers C, Yang X, Lassoued W, Sinkoe A, Papanicolau-Sengos A, Lee CC, Marte JL, Turkbey E, Mydlarz W, Joshi A, London NR Jr, Pierce M, Taylor R, Hong S, Nguyen A, Soon-Shiong P, Schlom J, Gulley JL, Allen CT. Redman JM, et al. Among authors: schlom j. J Clin Invest. 2022 Sep 15;132(18):e161400. doi: 10.1172/JCI161400. J Clin Invest. 2022. PMID: 35727629 Free PMC article. Clinical Trial.
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
Greene S, Robbins Y, Mydlarz WK, Huynh AP, Schmitt NC, Friedman J, Horn LA, Palena C, Schlom J, Maeda DY, Zebala JA, Clavijo PE, Allen C. Greene S, et al. Among authors: schlom j. Clin Cancer Res. 2020 Mar 15;26(6):1420-1431. doi: 10.1158/1078-0432.CCR-19-2625. Epub 2019 Dec 17. Clin Cancer Res. 2020. PMID: 31848188 Free PMC article.
NHS-IL12, a Tumor-Targeting Immunocytokine.
Greiner JW, Morillon YM 2nd, Schlom J. Greiner JW, et al. Among authors: schlom j. Immunotargets Ther. 2021 May 27;10:155-169. doi: 10.2147/ITT.S306150. eCollection 2021. Immunotargets Ther. 2021. PMID: 34079772 Free PMC article. Review.
Immunology of Lynch Syndrome.
Pastor DM, Schlom J. Pastor DM, et al. Among authors: schlom j. Curr Oncol Rep. 2021 Jun 14;23(8):96. doi: 10.1007/s11912-021-01085-z. Curr Oncol Rep. 2021. PMID: 34125344 Free PMC article. Review.
Combination therapies utilizing neoepitope-targeted vaccines.
Lee KL, Schlom J, Hamilton DH. Lee KL, et al. Among authors: schlom j. Cancer Immunol Immunother. 2021 Apr;70(4):875-885. doi: 10.1007/s00262-020-02729-y. Epub 2020 Oct 8. Cancer Immunol Immunother. 2021. PMID: 33033852 Free PMC article. Review.
Rationale for IL-15 superagonists in cancer immunotherapy.
Knudson KM, Hodge JW, Schlom J, Gameiro SR. Knudson KM, et al. Among authors: schlom j. Expert Opin Biol Ther. 2020 Jul;20(7):705-709. doi: 10.1080/14712598.2020.1738379. Epub 2020 Mar 11. Expert Opin Biol Ther. 2020. PMID: 32159390 No abstract available.
Therapeutic cancer vaccines.
Schlom J, Hodge JW, Palena C, Tsang KY, Jochems C, Greiner JW, Farsaci B, Madan RA, Heery CR, Gulley JL. Schlom J, et al. Adv Cancer Res. 2014;121:67-124. doi: 10.1016/B978-0-12-800249-0.00002-0. Adv Cancer Res. 2014. PMID: 24889529 Free PMC article. Review.
724 results